IGFBP5 and breast cancer: In the context of breast cancer, IGFBP-3 and IGFBP-5, secreted by carcinoma-associated fibroblasts (CAFs), inhibit detachment-induced cell death, known as anoikis, via regulation of ERK-MAPK activation (127).